Viewing StudyNCT05130866



Ignite Creation Date: 2024-05-06 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 2:18 PM
Study NCT ID: NCT05130866
Status: RECRUITING
Last Update Posted: 2024-03-01
First Post: 2021-11-10

Brief Title: Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 NF2 Mutated Meningiomas
Sponsor:
Organization: Recursion Pharmaceuticals Inc

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 92
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: